Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer

Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer

Heated intraperitoneal chemotherapy (HIPEC) has several potential benefits. Higher doses of chemotherapy can be used with HIPEC because the plasma-peritoneal barrier results in little absorption into the blood stream. HIPEC offers higher peritoneal penetration in comparison to an intravenous (IV) re...

Full description

Bibliographic Details
Main Authors:	Andrea Jewell, Megan McMahon, Dineo Khabele
Format:	Article
Language:	English
Published:	MDPI AG 2018-09-01
Series:	Cancers
Subjects:	ovarian cancer heated intraperitoneal chemotherapy (HIPEC) intraperitoneal chemotherapy (IP) cytoreductive surgery secondary cytoreduction interval cytoreduction
Online Access:	http://www.mdpi.com/2072-6694/10/9/296

Similar Items

A Four-Inflow Construction to Ensure Thermal Stability and Uniformity during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Rats
by: Daan R. Löke, et al.
Published: (2020-11-01)

The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
by: Guyu Zhang, et al.
Published: (2019-04-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer
by: Loss Martin, et al.
Published: (2004-06-01)

Multicystic peritoneal mesothelioma treated with cytoreductive surgery followed or not by hyperthermic intraperitoneal chemotherapy: results from a large multicentric cohort
by: Vahan Kepenekian, et al.
Published: (2021-01-01)

Complete Response for More than 4 Years following Neoadjuvant FOLFOX and Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for a Patient with Advanced Gastric Cancer with Extensive Peritoneal Carcinomatosis
by: Renata D’Alpino Peixoto, et al.
Published: (2018-05-01)

Drain site enterocutaneous fistula after hyperthermic intraperitoneal chemotherapy
by: Navin Kumar, et al.
Published: (2021-01-01)

Epididymitis following Cytoreductive Surgery with Intraperitoneal Oxaliplatin Chemotherapy: Two Case Reports
by: Luiza Damian Ribeiro Barbosa, et al.
Published: (2016-02-01)

Perioperative management and postoperative outcome of patients undergoing cytoreduction surgery with hyperthermic intraperitoneal chemotherapy
by: Hamed Elgendy, et al.
Published: (2019-01-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: our initial experience of implementation and detailed technique
by: Talgat Uskenbayev, et al.
Published: (2019-06-01)

Anesthesiological support of cytoreducative operations using hyperthermic intraperitoneal chemotherapy (hipec) in patients with ovaryan cancer
by: D. D. Morikov, et al.
Published: (2019-11-01)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer
by: Adriana C. Gamboa, et al.
Published: (2019-10-01)

Neoadjuvant Intraperitoneal Chemotherapy in Patients with Pseudomyxoma Peritonei—A Novel Treatment Approach
by: Aruna Prabhu, et al.
Published: (2020-08-01)

Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients
by: Anna Weiss, et al.
Published: (2018-04-01)

Pressurized intraperitoneal aerosol chemotherapy procedure for nonresectable peritoneal carcinomatosis: First Indian study
by: S P Somashekhar, et al.
Published: (2019-01-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)
by: W. J. Koemans, et al.
Published: (2019-05-01)

Impact of Neoadjuvant Chemotherapy on the Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Multi-Institutional Retrospective Review
by: Eliza W. Beal, et al.
Published: (2020-03-01)

Experience of applying cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian teratoma with malignant transformation and peritoneal dissemination
by: Yu HH, et al.
Published: (2019-01-01)

Anesthetic management in an appendix tumor patient undergoing hyperthermic chemotherapy
by: Yonca Yanlı, et al.
Published: (2013-06-01)

Data on the quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies: does it concern patients with gastric cancer?
by: Skierucha Malgorzata, et al.
Published: (2017-12-01)

THE EXPERIENCE AND RESULTS OF CYTOREDUCTIVE SURGERY AND HIPEC USED IN ADVANCED OVARIAN CANCER
by: Oleksandr Bondar, et al.
Published: (2020-10-01)

Hyperthermic intraperitoneal chemotherapy (HIPEC) in combined treatment of locally advanced and intraperitonealy disseminated gastric cancer: A retrospective cooperative Central‐Eastern European study
by: Roman Yarema, et al.
Published: (2019-06-01)

Anaesthetic management and perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: A retrospective analysis
by: Kalpana P Balakrishnan, et al.
Published: (2018-01-01)

Tonic-Clonic Seizure following Cytoreductive Surgery with Intraperitoneal Oxaliplatin: A Case Report and Review of the Literature
by: Jessica Sayuri Tsukamoto, et al.
Published: (2016-02-01)

Colorectal peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: The experience of a tertiary Asian center
by: Melissa Ching Ching Teo, et al.
Published: (2015-04-01)

Preclinical In Vivo-Models to Investigate HIPEC; Current Methodologies and Challenges
by: Roxan F. C. P. A. Helderman, et al.
Published: (2021-07-01)

Laparoscopic HIPEC: A bridge between open and closed-techniques
by: Marco Lotti, et al.
Published: (2016-01-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center
by: Yu HH, et al.
Published: (2017-10-01)

Does the primary tumour location affect the prognosis of patients with colorectal cancer peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?
by: Haipeng Chen, et al.
Published: (2021-08-01)

Neoadjuvant chemotherapy followed by hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastasis: a retrospective study of its safety and efficacy
by: Sicheng Zhou, et al.
Published: (2021-05-01)

Prognostic significance of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in predicting outcomes for peritoneal carcinomatosis patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Wei-Liang Loh, et al.
Published: (2017-01-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin in pediatric patients with peritoneal mesothelioma: a single institution experience and long term follow up
by: Parisa Malekzadeh, et al.
Published: (2021-01-01)

Cytoreductive Surgery and Hyperthermic İntraperitoneal Chemoterapy for Advance Gastric Cancer Associated Peritoneal Carcinomatosis Single Centre Unit for 10 Consecutive Patients
by: Özgül Düzgün, et al.
Published: (2019-09-01)

Incidence and predictors of incisional hernia after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Todd M. Tuttle, et al.
Published: (2019-01-01)

Comparative study of quality of life, adverse effects after cytoreduction and HIPEC in stage IIIA-IIIC ovarian cancer
by: A. I. Rybin, et al.
Published: (2018-10-01)

Adding Value of MRI Over CT in Predicting Peritoneal Cancer Index and Completeness of Cytoreduction
by: Chia-Ni Lin, et al.
Published: (2021-04-01)

Enhanced recovery after surgery (ERAS) in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a cross-sectional survey
by: Bhandoria Geetu, et al.
Published: (2021-06-01)

Cytoreduction with Hyperthermic Intraperitoneal Chemotherapy and Renal Insufficiency Related to Diabetes Mellitus: An Anesthetic Challenge
by: Bartos Adrian, et al.
Published: (2017-10-01)

Cytoreductive surgery and HIPEC (hyperthermic intraperitoneal chemotherapy) in combined treatment of ovarian cancer: time for the beginning of personalized therapy?
by: Yarema Roman, et al.
Published: (2019-09-01)

Factors Prognostic for Peritoneal Metastases from Colorectal Cancer Treated with Surgery
by: Chen C, et al.
Published: (2020-10-01)

Postoperative oxaliplatin-based hyperthermic intraperitoneal chemotherapy: an effective and safe palliative treatment option for colorectal cancer with peritoneal metastasis
by: Tuanhe Sun, et al.
Published: (2021-07-01)